Suppr超能文献

人类肝脏移植受者的感染:移植后早期和晚期的不同模式。

Infections in human liver recipients: different patterns early and late after transplantation.

作者信息

Barkholt L, Ericzon B G, Tollemar J, Malmborg A S, Ehrnst A, Wilczek H, Andersson J

机构信息

Department of Transplantation Surgery, Karolinska Institute, Huddinge Hospital, Sweden.

出版信息

Transpl Int. 1993 Mar;6(2):77-84. doi: 10.1007/BF00336649.

Abstract

The first 49 consecutive patients who underwent orthotopic liver transplantation between 1984 and 1989 in our department were studied with regard to symptomatic and asymptomatic post-transplantation infections. The major infections carrying a risk of fatal outcome are presented. During the first 4 weeks, fungal and bacterial infections predominated, the percentages of patients affected being 27% and 35%, respectively. Eight patients (17%) suffered from bacterial septicemia, which in six cases was due to gram-negative micro-organisms. The bacterial septicemia was often associated with severe ischemic damage to the graft, rejection, or cholangitis. In addition, a concomitant invasive fungal infection supervened in seven out of eight septic patients, further aggravating the patients' condition. Seventeen of the 49 patients (35%) died after transplantation within 3.3 years. Infection was the cause of death in nine patients (18%), with bacterial septicemia and/or fungemia in eight of these. Cytomegalovirus (CMV) disease was the dominant cause of illness after the 1st month. While only 5 of the 49 patients developed CMV disease during the 1st month (10%), as many as 16 of the 40 recipients who survived beyond that time suffered from symptomatic CMV viremia (40%). CMV mismatching, i.e., the donation of a CMV-positive organ to a CMV-seronegative recipient, entailed the highest risk for CMV disease. Pneumocystis carinii pneumonia occurred within 4 months in 10% of the patients. The four liver recipients affected were among the 20 patients not receiving trimethoprim-sulfamethoxazole prophylaxis. None of the 28 patients who received this prophylaxis over a 12-month period developed this complication (P < 0.005).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

对1984年至1989年间在我科接受原位肝移植的49例连续患者进行了移植后有症状和无症状感染方面的研究。文中列出了具有致命后果风险的主要感染情况。在最初4周内,真菌和细菌感染占主导,受影响患者的百分比分别为27%和35%。8例患者(17%)发生细菌性败血症,其中6例由革兰氏阴性微生物引起。细菌性败血症常与移植物严重缺血损伤、排斥反应或胆管炎相关。此外,8例败血症患者中有7例并发侵袭性真菌感染,使病情进一步恶化。49例患者中有17例(35%)在移植后3.3年内死亡。感染是9例患者(18%)的死亡原因,其中8例存在细菌性败血症和/或真菌血症。巨细胞病毒(CMV)疾病是第1个月后主要的致病原因。49例患者中仅5例(10%)在第1个月内发生CMV疾病,而在存活超过该时间的40例受者中,多达16例(40%)出现有症状的CMV病毒血症。CMV不匹配,即向CMV血清阴性受者捐赠CMV阳性器官,发生CMV疾病的风险最高。卡氏肺孢子虫肺炎在4个月内发生于10%的患者中。4例受影响的肝移植受者来自20例未接受甲氧苄啶 - 磺胺甲恶唑预防的患者。在12个月期间接受这种预防的28例患者中无一例发生此并发症(P < 0.005)。(摘要截短于250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验